問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK3475-564
Active

2017-06-01 - 2026-12-31

Phase III

Terminated5

ICD-10C64

Malignant neoplasm of kidney, except renal pelvis

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chao-Hsiang Chang Division of Radiation Therapy

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator CHUNG-HSIN CHEN Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Principal Investigator Chia-Yen Lin Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chao-Hsiang Chang 未分科

Co-Principal Investigator

Audit

None

Principal Investigator See-Tong Pang Division of Hematology & Oncology
Linkou Chang Gung Medical Foundation

Taiwan National PI

馮思中

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    950 participants